Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von Trip 

Insulet Corp. diskutieren

Insulet Corp.

WKN: A0MQX8 / Symbol: PODD / Name: Insulet / Aktie / Ausrüstung & Versorgung / Mid Cap /

247,40 €
-0,56 %

Einschätzung Buy
Rendite (%) -7,03 %
Kursziel 316,53
Veränderung
Endet am 16.06.26

Insulet Co. (NASDAQ: PODD) is now covered by analysts at Truist Financial Co.. They set a "buy" rating and a $365.00 price target on the stock.
Ratings data for PODD provided by MarketBeat

Insulet Corporation (NASDAQ: PODD) had its "buy" rating re-affirmed by analysts at Citigroup Inc..
Ratings data for PODD provided by MarketBeat

Insulet Corporation (NASDAQ: PODD) had its "buy" rating re-affirmed by analysts at Jefferies Financial Group Inc..
Ratings data for PODD provided by MarketBeat

Einschätzung Buy
Rendite (%) -6,22 %
Kursziel 300,13
Veränderung
Endet am 08.08.26

Insulet Corporation (NASDAQ: PODD) had its price target raised by analysts at Wells Fargo & Company from $330.00 to $350.00. They now have an "overweight" rating on the stock.
Ratings data for PODD provided by MarketBeat

Einschätzung Buy
Rendite (%) -6,22 %
Kursziel 300,13
Veränderung
Endet am 08.08.26

Insulet Corporation (NASDAQ: PODD) had its price target raised by analysts at Royal Bank Of Canada from $330.00 to $350.00. They now have an "outperform" rating on the stock.
Ratings data for PODD provided by MarketBeat

Einschätzung Buy
Rendite (%) -16,14 %
Kursziel 311,71
Veränderung
Endet am 08.09.26

Insulet (NASDAQ:PODD) is now covered by analysts at Oppenheimer Holdings, Inc.. They set an "outperform" rating and a $365.00 price target on the stock.
Ratings data for PODD provided by MarketBeat

Einschätzung Buy
Rendite (%) -9,21 %
Kursziel 350,05
Veränderung
Endet am 17.09.26

Insulet (NASDAQ:PODD) had its price target raised by analysts at JPMorgan Chase & Co. from $340.00 to $415.00. They now have an "overweight" rating on the stock.
Ratings data for PODD provided by MarketBeat

Einschätzung Buy
Rendite (%) -9,21 %
Kursziel 303,66
Veränderung
Endet am 17.09.26

Insulet (NASDAQ:PODD) had its price target raised by analysts at Piper Sandler from $320.00 to $360.00. They now have an "overweight" rating on the stock.
Ratings data for PODD provided by MarketBeat

Einschätzung Buy
Rendite (%) -1,71 %
Kursziel 319,43
Veränderung
Endet am 01.10.26

Insulet (NASDAQ:PODD) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $399.00 to $375.00. They now have a "buy" rating on the stock.
Ratings data for PODD provided by MarketBeat

Einschätzung Buy
Rendite (%) -5,72 %
Kursziel 315,13
Veränderung
Endet am 04.10.26

Insulet (NASDAQ:PODD) had its price target raised by analysts at Rothschild & Co Redburn from $350.00 to $370.00. They now have a "buy" rating on the stock.
Ratings data for PODD provided by MarketBeat

Einschätzung Buy
Rendite (%) -9,81 %
Kursziel 315,54
Veränderung
Endet am 10.10.26

Insulet (NASDAQ:PODD) had its price target raised by analysts at Royal Bank Of Canada from $350.00 to $365.00. They now have an "outperform" rating on the stock.
Ratings data for PODD provided by MarketBeat

Einschätzung Buy
Rendite (%) -9,58 %
Kursziel 306,79
Veränderung
Endet am 14.10.26

Insulet (NASDAQ:PODD) had its price target raised by analysts at Leerink Partners from $339.00 to $355.00. They now have an "outperform" rating on the stock.
Ratings data for PODD provided by MarketBeat

Einschätzung Buy
Rendite (%) -12,52 %
Kursziel 347,56
Veränderung
Endet am 06.11.26

Insulet (NASDAQ:PODD) had its price target raised by analysts at Jefferies Financial Group Inc. from $375.00 to $400.00. They now have a "buy" rating on the stock.
Ratings data for PODD provided by MarketBeat

Insulet (NASDAQ:PODD) had its "buy" rating reaffirmed by analysts at BTIG Research.
Ratings data for PODD provided by MarketBeat

Einschätzung Buy
Rendite (%) -13,13 %
Kursziel 312,01
Veränderung
Endet am 07.11.26

Insulet (NASDAQ:PODD) had its price target raised by analysts at Wells Fargo & Company from $350.00 to $360.00. They now have an "overweight" rating on the stock.
Ratings data for PODD provided by MarketBeat

Einschätzung Buy
Rendite (%) -13,13 %
Kursziel 333,68
Veränderung
Endet am 07.11.26

Insulet (NASDAQ:PODD) had its price target raised by analysts at Leerink Partners from $355.00 to $385.00. They now have an "outperform" rating on the stock.
Ratings data for PODD provided by MarketBeat

Einschätzung Buy
Rendite (%) -13,13 %
Kursziel 325,01
Veränderung
Endet am 07.11.26

Insulet (NASDAQ:PODD) had its price target raised by analysts at Wolfe Research from $350.00 to $375.00. They now have an "outperform" rating on the stock.
Ratings data for PODD provided by MarketBeat

Einschätzung Buy
Rendite (%) -13,13 %
Kursziel 317,21
Veränderung
Endet am 07.11.26

Insulet (NASDAQ:PODD) had its price target raised by analysts at Raymond James Financial, Inc. from $360.00 to $366.00. They now have an "outperform" rating on the stock.
Ratings data for PODD provided by MarketBeat

Einschätzung Buy
Rendite (%) -13,13 %
Kursziel 338,01
Veränderung
Endet am 07.11.26

Insulet (NASDAQ:PODD) had its price target raised by analysts at Truist Financial Corporation from $365.00 to $390.00. They now have a "buy" rating on the stock.
Ratings data for PODD provided by MarketBeat

Einschätzung Buy
Rendite (%) -10,62 %
Kursziel 320,68
Veränderung
Endet am 07.11.26

Insulet (NASDAQ:PODD) had its price target raised by analysts at Royal Bank Of Canada from $365.00 to $370.00. They now have an "outperform" rating on the stock.
Ratings data for PODD provided by MarketBeat